- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Rear Admiral Dr Wanda Barfield: How CDC's LOCATe Tool Assesses Risk-Appropriate Care
The CDC designed a tool to help identify a facility's level of maternal and neonatal care. Rear Admiral Wanda Barfield, MD, MPH, director of the Division of Reproductive Health for the CDC, discusses how it works to assess risk-appropriate care.
Transcript
The Centers for Disease Control and Prevention designeed LOCATe, a tool to help identify a facility's level of maternal and neonatal care. Can you discuss this tool and how it works to assess risk-appropriate care? What outcomes have you seen after the utilization of the LOCATe tool, and how does it improve maternal and child health?
So, the LOCATe tool is just that, it's a tool that helps public health leaders, as well as providers, to identify appropriate levels of care. It's an opportunity to utilize it on a broader scale, and to make general assessments about whether facilities are a certain level. If they're within a certain level, are they able to provide care appropriate for the population that they're serving.
LOCATe is an opportunity for health departments, as well as clinical providers, to assess the levels of care. That includes equipment, facilities, it also includes the skills within a particular facility to see whether it's a highest level of care, or a more basic level of care.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More
